Phone: +1 214-449-0201
Are you looking for a safe, customized approach to healing chronic or complex conditions? At PryorHealth, we offer TruDOSE Regenerative Technology, a precision-based therapy that supports your body’s natural ability to heal using your own biology.
At PryorHealth, we focus on identifying and addressing the root causes of chronic illness. TruDOSE Regenerative Technology™ allows us to deliver a personalized dose of your own blood platelets, helping your body repair and recover from the inside out.
We offer support for a wide range of conditions, including:
Every TruDOSE™ treatment is individualized based on your condition, goals, and overall health profile.
Dr. Landon Pryor, MD, FACS is a board-certified plastic surgeon and the founder, President, and CEO of PryorHealth. He provides a comprehensive range of surgical and non-surgical treatments, combining advanced aesthetics with wellness services to deliver natural, balanced results.
With a patient-centered philosophy, Dr. Pryor takes a holistic approach to care—focusing not only on appearance but also on helping patients improve their confidence, overall health, and quality of life. His mission at PryorHealth is to ensure that every patient has the opportunity to look good, feel good, and be good.
TruDOSE Regenerative Technology™ is not a supplement or general PRP therapy. It is an advanced regenerative therapy that delivers a precisely calibrated dose of your body’s own platelets, based on your unique biological profile.
Each certified provider is trained in this technology to ensure that every treatment is customized, consistent, and guided by your specific health needs.
We are currently accepting new patients. If you’re ready to explore TruDOSE Regenerative Technology, fill out the short form below. A team member from PryorHealth will follow up with you as soon as possible.
PryorHealth is a certified provider offering advanced regenerative platelet therapy for conditions such as autoimmune disease, chronic inflammation, Lyme disease, long COVID, and more.
